Gene · 21
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation. | Int J Mol Sci | 2022 | 35628648 | PubTator, text mining | PubMed |
| Consensus Gene Co-Expression Network Analysis Identifies Novel Genes Associated with Severity of Fibrotic Lung Disease. | Int J Mol Sci | 2022 | 35628257 | PubTator, text mining | PubMed |
| Diagnostic Challenges in Neonatal Respiratory Distress-Congenital Surfactant Metabolism Dysfunction Caused by ABCA3 Mutation. | Diagnostics (Basel) | 2022 | 35626240 | PubTator, text mining | PubMed |
| Understanding the Molecular Mechanism of Vestibular Schwannoma for Hearing Preservation Surgery: Otologists' Perspective from Bedside to Bench. | Diagnostics (Basel) | 2022 | 35626200 | PubTator, text mining | PubMed |
| Glutamine Metabolism Is Required for Alveolar Regeneration during Lung Injury. | Biomolecules | 2022 | 35625656 | PubTator, text mining | PubMed |
| Alectinib versus crizotinib in ALK-positive advanced non-small cell lung cancer and comparison of next-generation TKIs after crizotinib failure: Real-world evidence. | Cancer Med | 2022 | 35616090 | PubTator, text mining | PubMed |
| Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma. | Comput Math Methods Med | 2022 | 35592684 | PubTator, text mining | PubMed |
| Lysosome-mediated chemoresistance in acute myeloid leukemia. | Cancer Drug Resist | 2022 | 35582535 | PubTator, text mining | PubMed |
| Effectiveness and Safety of Anti-CD19 Chimeric Antigen Receptor-T Cell Immunotherapy in Patients With Relapsed/Refractory Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. | Front Pharmacol | 2022 | 35548364 | PubTator, text mining | PubMed |
| Neonatal lung-derived SSEA-1+ cells exhibited distinct stem/progenitor characteristics and organoid developmental potential. | iScience | 2022 | 35521516 | PubTator, text mining | PubMed |
| TGF-β receptor mutations and clinical prognosis in Chinese pediatric patients with idiopathic/hereditary pulmonary arterial hypertension. | Pulm Circ | 2022 | 35514780 | PubTator, text mining | PubMed |
| Sex-specific extracellular matrix remodeling during early adipogenic differentiation by gestational bisphenol A exposure. | Chemosphere | 2022 | 35504463 | PubTator, text mining | PubMed |
| New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium. | Clin Pharmacol Ther | 2022 | 35488474 | PubTator, text mining | PubMed |
| Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein. | Front Neurol | 2022 | 35481270 | PubTator, text mining | PubMed |
| Function of epithelial stem cell in the repair of alveolar injury. | Stem Cell Res Ther | 2022 | 35477551 | PubTator, text mining | PubMed |
| The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease. | Mol Neurodegener | 2022 | 35477481 | PubTator, text mining | PubMed |
| Case Report: Report of Two Cases of Interstitial Lung Disease Caused by Novel Compound Heterozygous Variants in the ABCA3 Gene. | Front Genet | 2022 | 35464853 | PubTator, text mining | PubMed |
| Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment. | Int J Mol Sci | 2022 | 35457264 | PubTator, text mining | PubMed |
| Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia. | Pharmaceutics | 2022 | 35456712 | PubTator, text mining | PubMed |
| Transcriptome Profile of Membrane and Extracellular Matrix Components in Ligament-Fibroblastic Progenitors and Cementoblasts Differentiated from Human Periodontal Ligament Cells. | Genes (Basel) | 2022 | 35456465 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/21/papers?page=18